Diagnostic tests and prognostic indicators
Minimal residual disease monitoring and immune profiling using second generation flow cytometry in elderlymultiple myeloma. Paiva B et al. Blood. 2016 Apr 26. pii: blood-2016-03-705319. [Epub ahead of print]. Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab. Postelnek J et al. AAPS J. 2016 Apr 26. [Epub…